Relative to its peers, VICL does not have very much institutional sponsorship. The 24.40% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
KCG AMERICAS LLC Bought 29.7 Thousand shares of Vical Inc
RENAISSANCE TECHNOLOGIES LLC Bought 23.5 Thousand shares of Vical Inc
THE VANGUARD GROUP, INC. Bought 14.8 Thousand shares of Vical Inc